Abstract:We identified Runx2 as a HSC‐specific protein during liver fibrosis, which is essential for the regulation of HSC activation. Targeted knockout of Runx2 expression in HSC or intrahepatic overexpression of Runx2 significantly inhibited or promoted liver fibrosis induced by various factors. Importantly, we demonstrated that PKA/Runx2/Itgav signaling is a probable mechanism for regulating HSC activation in liver fibrosis, and pharmacological blockade of Itgav attenuated Runx2‐induced HSC activation and liver fibrosis, which suggests a critical and yet unappreciated role of Runx2 in the development and progression of liver fibrosis, and may provide a potential new therapeutic target for liver fibrosis. Backgrounds and aims As a central event during liver fibrosis, hepatic stellate cells (HSC) have been thought to be a potential therapeutic target for liver fibrosis. Previous studies have shown that runt‐related transcription factor 2 (Runx2) is associated with the development of non‐alcoholic fatty liver disease, while its specific role in HSC activation and hepatic fibrosis remains elusive. Approach and results In this study, we found that Runx2 expression was significantly upregulated in human liver fibrosis with different aetiologies. Runx2 expression was also gradually elevated in mouse liver during fibrosis, and Runx2 was mainly expressed in the activated HSC. Knockdown of Runx2 in HSC markedly alleviated CCl4‐induced, 3,5‐diethoxycarbonyl‐1,4‐dihydrocollidine‐induced or methionine‐choline deficient (MCD)‐induced liver fibrosis, while hepatic overexpression of Runx2 via HBAAV‐Runx2 or VA‐Lip‐Runx2 injection exacerbated CCl4‐induced liver fibrosis. In vitro analysis demonstrated that Runx2 promoted HSC activation and proliferation, whereas Runx2 knockdown in HSC suppressed these effects. RNA‐seq and Runx2 ChIP‐seq analysis demonstrated that Runx2 could promote integrin alpha‐V (Itgav) expression by binding to its promoter. Blockade of Itgav attenuated Runx2‐induced HSC activation and liver fibrosis. Additionally, we found that cytokines (TGF‐β1, PDGF, EGF) promote the expression and nuclear translocation of Runx2 through protein kinase A (PKA) in HSC. Conclusions Runx2 is critical for HSC activation via transcriptionally regulating Itgav expression during liver fibrosis, and may be a promising therapeutic target for liver fibrosis.

Assessment of portosystemic shunt patency and function with magnetic resonance imaging.

The Endothelium as a Driver of Liver Fibrosis and Regeneration

Transcriptome Analyses of Liver Sinusoidal Endothelial Cells Reveal a Consistent List of Candidate Genes Associated with Endothelial Dysfunction and the Fibrosis Progression

Liver Sinusoidal Endothelial Cell: An Important Yet Often Overlooked Player in the Liver Fibrosis

The Upregulation of Leucine-Rich Repeat Containing 1 Expression Activates Hepatic Stellate Cells and Promotes Liver Fibrosis by Stabilizing Phosphorylated Smad2/3

Capillarized Liver Sinusoidal Endothelial Cells Undergo Partial Endothelial-Mesenchymal Transition to Actively Deposit Sinusoidal ECM in Liver Fibrosis

The role of sinusoidal endothelial cells and TIMP1 in the regulation of fibrosis in a novel human liver 3D NASH model

The HLF/IL-6/STAT3 Feedforward Circuit Drives Hepatic Stellate Cell Activation to Promote Liver Fibrosis

Targeting Endothelial Erk1/2-Akt Axis As a Regeneration Strategy to Bypass Fibrosis During Chronic Liver Injury in Mice.

Runx2 activates hepatic stellate cells to promote liver fibrosis via transcriptionally regulating Itgav expression

SECs (Sinusoidal Endothelial Cells), Liver Microenvironment, and Fibrosis

KLF10 Inhibits TGF-β-Mediated Activation of Hepatic Stellate Cells via Suppression of ATF3 Expression

The mouse homolog to the ras-related yeast gene YPT1 maps on Chromosome 11 close to the wobbler (wr) locus

Modulation of transforming growth factor-β-induced kidney fibrosis by leucine-rich ⍺-2 glycoprotein-1

Regulatory T cells (Tregs) in liver fibrosis

Immunonano-Lipocarrier-Mediated Liver Sinusoidal Endothelial Cell-Specific RUNX1 Inhibition Impedes Immune Cell Infiltration and Hepatic Inflammation in Murine Model of NASH

Liver sinusoidal endothelial cells as potential drivers of liver fibrosis (Review)

Endothelial POFUT1 controls injury-induced liver fibrosis by repressing fibrinogen synthesis

Runt-related transcription factor-1 ameliorates bile acid–induced hepatic inflammation in cholestasis through JAK/STAT3 signaling

LncRNA H19-EZH2 interaction promotes liver fibrosis via reprogramming H3K27me3 profiles